{
    "clinical_study": {
        "@rank": "38397", 
        "arm_group": {
            "arm_group_label": "port wine stain", 
            "arm_group_type": "No Intervention", 
            "description": "port wine stain"
        }, 
        "brief_summary": {
            "textblock": "Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin.\n      However, even though the pulsed dye laser is considered as the treatment of choice for Port\n      wine stain Birthmark the degree of fading can remain variable and unpredictable after laser\n      treatment."
        }, 
        "brief_title": "Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Port-Wine Stain", 
        "condition_browse": {
            "mesh_term": "Port-Wine Stain"
        }, 
        "detailed_description": {
            "textblock": "The researcher want to use the combination of radiofrequency electrical energy with pulsed\n      dye laser light energy which can improve therapeutic outcome of Port wine stain Birthmark.\n      This investigational device is essentially a combination of two commercially available\n      systems cleared for marketing (K044351 and K052324) provided by Candela Laser Corporation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Port Wine Stain suitable for comparison testing\n\n          2. Age > 12 years of age; minor will be accompanied in the room by parents or guardians\n             during laser treatment\n\n          3. Apparent good health as documented by medical history\n\n          4. Ability to understand and carry out subject instructions\n\n        Exclusion Criteria:\n\n          1. History of photodermatoses or skin cancer\n\n          2. Any therapy within the previous two months to the proposed port wine stain treatment\n             sites\n\n          3. Current participation in any other investigational drug or device evaluation\n\n          4. Concurrent use of known photosensitizing drugs\n\n          5. Inability to understand and carry out instructions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01775722", 
            "org_study_id": "NIH-Arthritis-RO1"
        }, 
        "intervention": {
            "arm_group_label": "port wine stain", 
            "description": "port wine stain", 
            "intervention_name": "port wine stain", 
            "intervention_type": "Device", 
            "other_name": "candela-Laser"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "contact": {
                "email": "mocomton@uci.edu", 
                "last_name": "Montana Compton, RN", 
                "phone": "949-824-9265"
            }, 
            "facility": {
                "address": {
                    "city": "Irvine", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92612"
                }, 
                "name": "Beckman Laser Institute Medical Clinic"
            }, 
            "investigator": [
                {
                    "last_name": "John Stuart Nelson, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Wangcun Jia, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Montana Compton, RN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Combined Bipolar Radiofrequency and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks", 
        "overall_contact": {
            "email": "mocomton@uci.edu", 
            "last_name": "Montana Compton, RN", 
            "phone": "949-824-9265"
        }, 
        "overall_official": {
            "affiliation": "Beckman Laser Institute, UCI", 
            "last_name": "J. Stuart Nelson, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "combined radiofrequency electrical energy with pulsed dye laser will improve  Port wine stain  outcome", 
            "safety_issue": "Yes", 
            "time_frame": "up to 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01775722"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of California, Irvine", 
            "investigator_full_name": "Montana Compton", 
            "investigator_title": "Administrative Nurse Research Coordinator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "University of California, Irvine", 
        "sponsors": {
            "collaborator": {
                "agency": "Candela Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Montana Compton", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}